Myeloablative doses of yttrium-90-ibritumomab tiuxetan and the risk of secondary myelodysplasia/acute myelogenous leukemia
scientific article published on 12 May 2011
Author/s
author: Anna Guidetti, Carmelo Carlo-Stella, Marco Ruella, Rosalba Miceli, Liliana Devizzi, Arianna Giacomini, Maria Adele Testi, Luigi Mariani, Massimo Di Nicola, Roberto Passera, Corrado Tarella
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.